Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

Autor:	Roca, Maria Serena, Moccia, Tania, Iannelli, Federica, Testa, Cristina, Vitagliano, Carlo, Minopoli, Michele, Camerlingo, Rosa, De Riso, Giulia, De Cecio, Rossella, Bruzzese, Francesca, Conte, Mariarosaria, Altucci, Lucia, Di Gennaro, Elena, Avallone, Antonio, Leone, Alessandra, Budillon, Alfredo
Předmět:	CANCER stem cells CANCER chemotherapy PANCREATIC cancer PANCREATIC intraepithelial neoplasia BORTEZOMIB PANCREATIC tumors
Zdroj:	Journal of Experimental & Clinical Cancer Research (17569966); 4/11/2022, Vol. 41 Issue 1, p1-4, 4p
Abstrakt:	O OCT4, CAT, SOD2 and GPX2 mRNA levels in PANC1 cells transfected with FOXM1 (OE-FOXM1) or empty vector (EV-FOXM1). Q OE-FOXM1 and EV-FOXM1 PANC1 cells were treated for 96 h with domatinostat (1 M) alone or in combination with GT (respectively, 100 nM and 1.56 nM). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.